| 1/8 | US=94 / Biol/Mol Matthews DJ, Gerritsen ME. Cell cycle control. In: ___. Targeting protein kinases for cancer therapy. New Jersey: Wiley, 2010. p. 327-90. ISBN 978-0-470-22965-1. CICLO CELULAR; QUINASES CICLICAS DEPENDENTES (CDK); CDK4; CDK6; CDK2; CDK3; CDK1; CDK10; CCRK; CDCH; PRODUCAO DE MRNA; CDK7; CDK8; CDK9; CDK11; CDK12; CDK13; CDK5; QUINASE CICLINA G-ASSOCIADOS (GAK); QUINASES MITOTICAS; QUINASE POLO-LIKE (PLK); AURORA-QUINASE; ATAXIA-TELANGIECTASIA MUTADO (ATM); ATAXIA TELANGIECTASIA E PROTEINA RAD3 RELACIONADOS (ATR); CHK1; CHK2; MAPKAPK2 |
| 2/8 | US=10 / Cirurgia Benson EA, Wedgwood KR, Axon ATR, Reis LDO. Coledocolitíase. In: Coelho JCU. Manual de clínica cirúrgica: cirurgia geral e especialidades. São Paulo: Atheneu, 2009. p. 1307-13. ISBN 85-388-0009-5. COLEDOCOLITIASE. ETIOLOGIA; COLEDOCOLITIASE. DIAGNOSTICO; COLEDOCOLITIASE. TRATAMENTO |
| 3/8 | US=66 / Biol/Mol Dimitrova N. Telomere-binding proteins in humans. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 23-46. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. TELOMERE PROTEINAS DE LIGACAO EM HUMANOS; SHELTERIN; T-LOOP; CAIXA ELETRONICO; ATR; NHEJ; HR |
| 4/8 | US=3-C / Clín/Médica Salant DJ, Patel PS. Doença renal policística e outros distúrbios tubulares hereditários. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison medicina interna. 17ª ed. Rio de Janeiro: McGraw-Hill, 2008. p. 1797-806. ISBN 85-7726051-5. DOENCA RENAL POLICISTICA; DISTURBIOS TUBULARES HEREDITARIOS; NEFRONOFTISE; DOENCA CISTICA MEDULAR DO RIM; RIM ESPONJASO MEDULAR; SINDROME DE BARTTER E GITELMAN; DIABETES INSIPIDO NEFROGENICO; ATR TIPO 1 - DISTAL; ATR TIPO 2 - PROXIMAL; CISTINURIA; DOENCAS DE DENT |
| 5/8 | US=47 / Câncer Ackermann JM, El-Deiry WS. Targeting ATM/ATR in the DNA damage checkpoint. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 93-116. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. SEGMENTACAO ATM/ATR; DANOS AO DNA; ATAXIA TELANGIECTASIA; RADIACAO IONIZANTE; FOSFORILACAO |
| 6/8 | US=58 / Câncer Hurley PJ, Bunz F. Distinct pathways involved in s-phase checkpoint control. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 27-36. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. CONTROLO S-CHECKPOINT; INTRA-S-FASE CHECKPOIN; CHECKPOIN REPLICACAO; S-M CHECKPOINT; ATR; CHK1; CHK2; REPLICACAO DO DNA |
| 7/8 | US=58 / Câncer Kaina B, Roos WP, Christmann M. DNA damage response and the balance between cell survival and cell death. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 95-108. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. DANOS NO DNA; SOBREVIVENCIA CELULAR; MORTE CELULAR; CHECKPOINTS; CICLO CELULAR; RESPOSTA A DANOS DO DNA; REPARACAO DO ADN; P53; APOPTOSE; RECEPTORES DE MORTE; FAS; CAIXA ELETRONICO; ATR; DROGAS ANTICANCER |
| 8/8 | US=92 / Biol/Mol Dupré A, Gautier J. DNA damage response, signalling pathways, and tumorigenesis: overview of the DNA damage checkpoint. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 193-221. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ATM; ATR; CHECKPOINTS; REPLICA; CADEIA SIMPLES DE DNA; REPARO DE QUEBRA DE DUPLA FITA DO DNA |